Scientists prioritize experimental therapies for Bundibugyo Ebola trials

Global health experts have prioritized several antiviral drugs and monoclonal antibodies for clinical trials against Bundibugyo virus disease (BVD), following a technical meeting convened to review potential medical countermeasures for the rare Ebola strain. The meeting focused on the current landscape of therapeutics for Bundibugyo virus disease and reviewed evidence for specific products including remdesivir,…